Contineum Therapeutics, Inc. Class A Ownership | Who Owns Contineum Therapeutics, Inc. Class A?

Contineum Therapeutics, Inc. Class A Ownership Summary

Contineum Therapeutics, Inc. Class A is owned by 8.84% institutional investors, 1.51% insiders, and 89.66% retail investors. Ra capital management is the largest institutional shareholder, holding 8.19% of CTNM shares.

CTNM Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Contineum Therapeutics, Inc. Class A	8.84%	1.51%	89.66%
Sector	Healthcare Stocks	42.50%	10.81%	46.69%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	2.12M	8.19%	$24.93M
Johnson & johnson	1.98M	7.64%	$23.26M
Suvretta capital management	1.72M	6.64%	$20.21M
Franklin resources	1.66M	6.39%	$19.45M
Vanguard group	964.23K	3.72%	$11.33M
Fmr	814.87K	3.15%	$9.57M
Sectoral asset management	800.79K	3.09%	$9.41M
Perceptive advisors	714.59K	2.76%	$8.40M
Hhlr advisors	669.34K	2.58%	$7.86M
Red tree management	638.16K	2.46%	$7.50M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Red tree management	638.16K	9.04%	$7.50M
Sectoral asset management	800.79K	5.81%	$9.41M
Johnson & johnson	1.98M	4.62%	$23.26M
Versant venture management	542.63K	3.00%	$6.38M
Samsara biocapital	571.14K	0.88%	$6.71M
Suvretta capital management	1.72M	0.52%	$20.21M
Ra capital management	2.12M	0.31%	$24.93M
Silverarc capital management	166.16K	0.26%	$1.95M
Perceptive advisors	714.59K	0.24%	$8.40M
Hhlr advisors	669.34K	0.19%	$7.86M

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	2.12M	0.31%	2.12M
Vanguard group	964.23K	0.00%	220.23K
Silverarc capital management	166.16K	0.26%	166.16K
Marshall wace, llp	193.49K	0.00%	164.81K
Blackrock funding, inc. /de	322.03K	0.00%	156.59K

Top Sellers

Holder	Shares	% Assets	Change
Saturn v capital management	-	-	-319.35K
Stempoint capital lp	-	-	-265.83K
Baker bros. advisors lp	77.67K	0.01%	-234.83K
Adage capital partners gp	-	-	-200.00K
Schonfeld strategic advisors	18.50K	0.00%	-145.63K

New Positions

Holder	Shares	% Assets	Change	Value
Ra capital management	2.12M	0.31%	2.12M	$24.93M
Silverarc capital management	166.16K	0.26%	166.16K	$1.95M
Eversept partners, lp	134.62K	0.11%	134.62K	$1.58M
Trexquant investment lp	29.31K	0.00%	29.31K	$344.39K
Baker ellis asset management	19.50K	0.03%	19.50K	$229.13K

Sold Out

Holder	Change
Advisor group	-10.00
Cubist systematic strategies	-24.00
Golden state wealth management	-27.00
Clearstead advisors	-33.00
Private wealth management group	-43.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	12	-82.86%	2,288,931	-83.48%	8	0.31%	7	-82.93%	3	-85.71%
Jun 30, 2025	69	13.11%	13,845,129	2.06%	53	1.94%	40	42.86%	21	16.67%
Mar 31, 2025	62	5.08%	15,117,518	-3.45%	58	0.89%	27	-30.77%	18	100.00%
Dec 31, 2024	60	17.65%	15,782,189	16.07%	81	2.92%	40	66.67%	9	-40.00%
Sep 30, 2024	51	4.08%	13,597,553	4.46%	52	2.06%	24	-51.02%	15	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 25, 2024	Lorrain Daniel S.	Chief Scientific Officer	Sell	$16.18K
Nov 18, 2024	Lorrain Daniel S.	Chief Scientific Officer	Sell	$99.73K
Nov 18, 2024	Lorrain Daniel S.	Chief Scientific Officer	Sell	$1.69K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	3
2024 Q2	-	-

CTNM Ownership FAQ

Who Owns Contineum Therapeutics, Inc. Class A?

Contineum Therapeutics, Inc. Class A shareholders are primarily institutional investors at 8.84%, followed by 1.51% insiders and 89.65% retail investors. The average institutional ownership in Contineum Therapeutics, Inc. Class A's industry, Biotech Stocks , is 45.24%, which Contineum Therapeutics, Inc. Class A falls below.

Who owns the most shares of Contineum Therapeutics, Inc. Class A?

Contineum Therapeutics, Inc. Class A’s largest shareholders are Ra capital management (2.12M shares, 8.19%), Johnson & johnson (1.98M shares, 7.64%), and Suvretta capital management (1.72M shares, 6.64%). Together, they hold 22.48% of Contineum Therapeutics, Inc. Class A’s total shares outstanding.

Does Blackrock own Contineum Therapeutics, Inc. Class A?

BlackRock is not among the top 10 institutional shareholders of Contineum Therapeutics, Inc. Class A.

Who is Contineum Therapeutics, Inc. Class A’s biggest shareholder by percentage of total assets invested?

Red tree management is Contineum Therapeutics, Inc. Class A’s biggest shareholder by percentage of total assets invested, with 9.04% of its assets in 638.16K Contineum Therapeutics, Inc. Class A shares, valued at 7.5M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools